clinical trials

Commentary – Suffering From Mild Depression

  Commentary – Suffering from Mild Depression – Feels good to let this off my chest Watch PART 2 HERE!: http://www.youtube.com/watch?v=XOjfxj7MUo4 Links: Twitter: https://twitter.com/BrandonJLPs Skype: bra…   by steelskyblue How I Overcame Depression and Became the Happy Nomad It could be one thing after another going wrong, illness, or just waking up on the wrong side of the bed, but on rare occasions I most certainly face some mild depression. The difference now is that it's always temporary, never severe, and isn't harmful. Read more on Huffington Post Read more... ...

What Is the Difference in the Number of Positive Responders to SSRI’s and Placebo?

...  by : What is the difference in the number of positive responders to SSRI’s and placebo? In clinical trials what is on average the difference in the number of positive responders between SSRIs and placebo for the treatment of depression? Please can you also refer to medical articles or websites if possible. Thankyou thefreevariable it’s a very interesting link. Hi David D. thankyou for your interesting answer. Because of these differences in results, from none to large differences compared to placebo I do agree that doctors should discuss this with patients. The difference ...

Does Cell Therapy Hold the Key to Treating Stroke?

...  Cell Therapy Hold The Key To Treating Stroke? The goal of this article is to introduce investors to the core technologies at each firm, outline each of their clinical trials currently underway in stroke, and provide a brief conclusion as to why we think cell therapy may offer hope where others … Read more on Seeking Alpha May Is Stroke Awareness Month: Think FAST To learn more about neurosciences at Bronson, visit bronsonhealth.com/neuro. Bronson offers acute care and outpatient neurological rehabilitation for stroke patients. This includes speech-language pathology, occupational therapy and physical therapy. Read more on Comvoicesonline Read ...

FDA Approves Neuralstem to Treat Final Cohort in NSI-189 Phase Ib Trial in

...  22, 2013 /PRNewswire/ — Neuralstem, Inc. (NYSE MKT: CUR) announced that it has received approval from the Food and Drug Administration (FDA) to begin dosing the third and final cohort of patients in its ongoing Phase Ib to test … Read more on PR Newswire (press release) NeuroSigma Receives Health Canada Approval for Its Monarch eTNS System … After 18 weeks of eTNS therapy, 40.5% of patients in the treatment group had a reduction in seizures of at least 50%. In addition to clinical trials in epilepsy, NeuroSigma has funded clinical trials at UCLA for the treatment of major depression, PTSD … Read more on PR Newswire (press release) Read ...

Johnny Depp Drug Abuse: Katy Perry, Eminem and Johnny Depp Rule at People’s Choice Awards 2011

THE LONG awaited People’s Choice Awards 2011 left the audiences as well as the spectators bedazzled when a host of awards were given out to some of the best names in the business which included Johnny Depp, Robert Pattinson and Taylor Lautner, Adam Sandler and actor Zac Efron. Adding colour to the entire event were the Kardashian siblings including Khloe, who walked in with her red tresses along with her husband. Her sisters, Kim and Kourtney were seen giving company to her. Read more... ...

Editorial Roundup: Excerpts From Recent Editorials – Newsday

Editorial Roundup: Excerpts from recent editorials – Newsday The 577-page study confirms previously reported abuses by military and intelligence personnel at detention centers in Iraq and Afghanistan, secret CIA prisons in Eastern Europe and Guantanamo Bay in Cuba. It also validates a report that … The report … Read more on Newsday Trimel Pharmaceuticals Corporation Announces Terms of Million Equity … The Company intends to use the net proceeds from the sale of Common Shares to pay for the costs of completing the CompleoTRT™ New Drug Application, payment of certain milestone payments related to CompleoTRT™, manufacturing scale-up costs and … Read more on Marketwire (press release) Read more... ...

Cancer Drug That Shrinks All Tumors Set to Begin Human Clinical Trials

...  Drug That Shrinks All Tumors Set To Begin Human Clinical Trials After publishing their findings in the Proceedings of the National Academy of Science, the team tested the drug treatment on mice with seven different types of human cancer tumors — breast, ovary, colon, bladder, brain, liver and prostate. … origins … Read more on Huffington Post Fallout from fungal meningitis crisis continues Many patients don't know how long they'll need to take powerful anti-fungal drugs — or if they'll ever fully recover. ...